These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11683006)
41. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217. Messer K; Vaida F; Hogan C Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381 [TBL] [Abstract][Full Text] [Related]
42. New type of experimental nucleoside (1592) in human trials. AIDS Patient Care STDS; 1996 Dec; 10(6):377. PubMed ID: 11361562 [No Abstract] [Full Text] [Related]
43. Anti-HIV agents. How long will a first regimen last? TreatmentUpdate; 2003; 15(5):1-2. PubMed ID: 17219614 [No Abstract] [Full Text] [Related]
45. [Reactions to the New York "supervirus". A challenge in primary resistance]. Paukstadt W MMW Fortschr Med; 2005 Apr; 147 Spec No 1():86. PubMed ID: 16385890 [No Abstract] [Full Text] [Related]
46. Anti-HIV agents. Is FOTO a treatment interruption that works? TreatmentUpdate; 2005; 17(5):10-1. PubMed ID: 17219661 [No Abstract] [Full Text] [Related]
48. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC; Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643 [TBL] [Abstract][Full Text] [Related]
49. Antiretroviral suppression of HIV in the context of persistently low CD4 counts: new insights. Laurence J AIDS Read; 2007 Jan; 17(1):7, 18. PubMed ID: 17274141 [No Abstract] [Full Text] [Related]
50. Too smart for our own good. Barr D Res Initiat Treat Action; 2001; 7(1):25-7. PubMed ID: 11548385 [No Abstract] [Full Text] [Related]
51. Zinc finger inhibitor for HIV. Treat Rev; 1996 Dec; (No 23):13. PubMed ID: 11364280 [TBL] [Abstract][Full Text] [Related]
52. Antiretroviral update from the 46th ICAAC. Gallant JE Hopkins HIV Rep; 2007 Jan; 19(1):1-3, 12. PubMed ID: 17569167 [No Abstract] [Full Text] [Related]
53. The role of gender in HIV progression. Hewitt RG; Parsa N; Gugino L BETA; 2001; 14(1):13-6. PubMed ID: 11695332 [No Abstract] [Full Text] [Related]
55. Antiretroviral therapy for HIV infection: promises and problems. Volberding PA; Deeks SG JAMA; 1998 May; 279(17):1343-4. PubMed ID: 9582033 [No Abstract] [Full Text] [Related]
56. AIDS clinical research for New Yorkers. GMHC Treat Issues; 2001 May; 15(5):11. PubMed ID: 11548300 [No Abstract] [Full Text] [Related]
57. 14th annual retrovirus conference (CROI). New drugs at CROI: the four musketeers. New drugs new targets, new hope. Berry J Posit Aware; 2007; 18(3):21-3. PubMed ID: 17526109 [No Abstract] [Full Text] [Related]
58. Meeting report from the XV International AIDS Conference. Clinical trials of approved antiretrovirals. Feinberg J AIDS Clin Care; 2004 Sep; 16(9):70-1. PubMed ID: 15540315 [No Abstract] [Full Text] [Related]
59. Outcomes of a trial of HIV-1 immunogen in patients with HIV infection. Dat NV JAMA; 2001 May; 285(17):2191; 2193-5. PubMed ID: 11325312 [No Abstract] [Full Text] [Related]
60. Report from the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Sax PE AIDS Clin Care; 2006 Mar; 18(3):25-6. PubMed ID: 16598868 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]